Cargando…
Correction: Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation
Autores principales: | Sun, Shao-Qian, Gu, Xiaobin, Gao, Xian-Shu, Li, Yi, Yu, Hongliang, Xiong, Wei, Yu, Hao, Wang, Wen, Li, Yingbo, Teng, Yingqi, Zhou, Demin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197445/ https://www.ncbi.nlm.nih.gov/pubmed/32391126 http://dx.doi.org/10.18632/oncotarget.27542 |
Ejemplares similares
-
Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation
por: Sun, Shao-Qian, et al.
Publicado: (2016) -
Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
por: Li, Xiaoying, et al.
Publicado: (2018) -
Elevated Expression of AKR1C3 Increases Resistance of Cancer Cells to Ionizing Radiation via Modulation of Oxidative Stress
por: Xiong, Wei, et al.
Publicado: (2014) -
AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
por: Tian, Yuantong, et al.
Publicado: (2014) -
AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
por: Gao, Cheng, et al.
Publicado: (2023)